BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21559395)

  • 1. Modeling initiation of Ewing sarcoma in human neural crest cells.
    von Levetzow C; Jiang X; Gwye Y; von Levetzow G; Hung L; Cooper A; Hsu JH; Lawlor ER
    PLoS One; 2011 Apr; 6(4):e19305. PubMed ID: 21559395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
    Coles EG; Lawlor ER; Bronner-Fraser M
    Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing's sarcoma cancer stem cell targeted therapy.
    Todorova R
    Curr Stem Cell Res Ther; 2014 Jan; 9(1):46-62. PubMed ID: 24294922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
    Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
    Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
    Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors.
    Joo J; Christensen L; Warner K; States L; Kang HG; Vo K; Lawlor ER; May WA
    PLoS One; 2009 Oct; 4(10):e7608. PubMed ID: 19859563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
    Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.
    Grohar PJ; Griffin LB; Yeung C; Chen QR; Pommier Y; Khanna C; Khan J; Helman LJ
    Neoplasia; 2011 Feb; 13(2):145-53. PubMed ID: 21403840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
    Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
    J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
    Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
    Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
    Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
    De Vito C; Riggi N; Suvà ML; Janiszewska M; Horlbeck J; Baumer K; Provero P; Stamenkovic I
    PLoS One; 2011; 6(8):e23592. PubMed ID: 21853155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.
    Richter GH; Plehm S; Fasan A; Rössler S; Unland R; Bennani-Baiti IM; Hotfilder M; Löwel D; von Luettichau I; Mossbrugger I; Quintanilla-Martinez L; Kovar H; Staege MS; Müller-Tidow C; Burdach S
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5324-9. PubMed ID: 19289832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.
    Beauchamp E; Bulut G; Abaan O; Chen K; Merchant A; Matsui W; Endo Y; Rubin JS; Toretsky J; Uren A
    J Biol Chem; 2009 Apr; 284(14):9074-82. PubMed ID: 19189974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
    Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
    Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.